miR-19a and miR-424 target TGFBR3 to promote epithelial-to-mesenchymal transition and migration of tongue squamous cell carcinoma cells

Strategies to use microRNAs as therapeutic targets

(2016) Jan Krützfeldt   BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM

MicroRNA-328, a Potential Anti-Fibrotic Target in Cardiac Interstitial Fibrosis

(2016) Weijie Du et al.   CELLULAR PHYSIOLOGY AND BIOCHEMISTRY

MiR-424-5p participates in esophageal squamous cell carcinoma invasion and metastasis via SMAD7 pathway mediated EMT

(2016) Feng Wang et al.   Diagnostic Pathology

Micronome revealed miR-19a/b as key regulator of SOCS3 during cancer related inflammation of oral squamous cell carcinoma

(2016) Ajay Francis Christopher et al.   GENE

Type III Transforming Growth Factor-β Receptor Drives Cardiac Hypertrophy Through β-Arrestin2–Dependent Activation of Calmodulin-Dependent Protein Kinase IINovelty and Significance

(2016) Jie Lou et al.   HYPERTENSION

Regulation of myofibroblast differentiation by miR-424 during epithelial-to-mesenchymal transition

(2015) Xiao Xiao et al.   ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS

FGF1–FGFR1 axis promotes tongue squamous cell carcinoma (TSCC) metastasis through epithelial–mesenchymal transition (EMT)

(2015) Jiuyang Jiao et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Overexpression of transforming growth factor type III receptor restores TGF- 1 sensitivity in human tongue squamous cell carcinoma cells

(2015) D. Li et al.   BIOSCIENCE REPORTS

Simvastatin alleviates cardiac fibrosis induced by infarction via up-regulation of TGF-β receptor III expression

(2015) Fei Sun et al.   BRITISH JOURNAL OF PHARMACOLOGY

MicroRNA-19 triggers epithelial–mesenchymal transition of lung cancer cells accompanied by growth inhibition

(2015) Jing Li et al.   LABORATORY INVESTIGATION

MicroRNAs as prognostic molecular signatures in human head and neck squamous cell carcinoma: A systematic review and meta-analysis

(2015) Zahra Jamali et al.   ORAL ONCOLOGY

Hsa-miR-19a is associated with lymph metastasis and mediates the TNF-α induced epithelial-to-mesenchymal transition in colorectal cancer

(2015) Lanlan Huang et al.   Scientific Reports

Type III TGF-β Receptor Enhances Colon Cancer Cell Migration and Anchorage-Independent Growth

(2015) Catherine E. Gatza et al.   NEOPLASIA

Role of TGF-β receptor III localization in polarity and breast cancer progression

(2014) Alison E. Meyer et al.   MOLECULAR BIOLOGY OF THE CELL

Resveratrol Inhibits the Epithelial-Mesenchymal Transition of Pancreatic Cancer Cells Via Suppression of the PI-3K/Akt/NF-κB Pathway

(2013) Wei Li et al.   CURRENT MEDICINAL CHEMISTRY

Treatment of cT1N0M0 Tongue Cancer: Outcome and Prognostic Parameters

(2013) Tao Zhang et al.   JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY

Regulation of epithelial plasticity by miR-424 and miR-200 in a new prostate cancer metastasis model

(2013) Jacqueline Banyard et al.   Scientific Reports

Downregulation of TGF-beta receptor types II and III in oral squamous cell carcinoma and oral carcinoma-associated fibroblasts

(2011) Wenxia Meng et al.   BMC CANCER

Andrographolide Inhibits Oral Squamous Cell Carcinogenesis through NF-κB Inactivation

(2011) L.-J. Wang et al.   JOURNAL OF DENTAL RESEARCH

Betaglycan: A multifunctional accessory

(2011) Maree Bilandzic et al.   MOLECULAR AND CELLULAR ENDOCRINOLOGY

The type III transforming growth factor-β receptor inhibits proliferation, migration, and adhesion in human myeloma cells

(2011) Kathleen E. Lambert et al.   MOLECULAR BIOLOGY OF THE CELL

Roles for the type III TGF-β receptor in human cancer

(2010) Catherine E. Gatza et al.   CELLULAR SIGNALLING

The type III TGF-β receptor suppresses breast cancer progression through GIPC-mediated inhibition of TGF-β signaling

(2009) Jason D. Lee et al.   CARCINOGENESIS

The type III transforming growth factor-  receptor negatively regulates nuclear factor kappa B signaling through its interaction with  -arrestin2

(2009) H. J. You et al.   CARCINOGENESIS

The Transforming Growth Factor-β Type III Receptor Mediates Distinct Subcellular Trafficking and Downstream Signaling of Activin-like Kinase (ALK)3 and ALK6 Receptors

(2009) Nam Y. Lee et al.   MOLECULAR BIOLOGY OF THE CELL